AU4543196A - Transfert of dna in cells with the view to correcting the adrenoleucodystrophy - Google Patents

Transfert of dna in cells with the view to correcting the adrenoleucodystrophy

Info

Publication number
AU4543196A
AU4543196A AU45431/96A AU4543196A AU4543196A AU 4543196 A AU4543196 A AU 4543196A AU 45431/96 A AU45431/96 A AU 45431/96A AU 4543196 A AU4543196 A AU 4543196A AU 4543196 A AU4543196 A AU 4543196A
Authority
AU
Australia
Prior art keywords
adrenoleucodystrophy
transfert
correcting
dna
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45431/96A
Inventor
Patrick Aubourg
Jean-Louis Mandel
Jean Mosser
Claude-Olivier Sarde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of AU4543196A publication Critical patent/AU4543196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU45431/96A 1995-01-13 1996-01-12 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy Abandoned AU4543196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9500376 1995-01-13
FR9500376A FR2729399B1 (en) 1995-01-13 1995-01-13 RECOMBINANT RETROVIRAL VECTOR FOR CORRECTION OF GENE TRANSFER ADRENOLEUCODYSTROPHY
PCT/FR1996/000059 WO1996021733A2 (en) 1995-01-13 1996-01-12 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy

Publications (1)

Publication Number Publication Date
AU4543196A true AU4543196A (en) 1996-07-31

Family

ID=9475123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45431/96A Abandoned AU4543196A (en) 1995-01-13 1996-01-12 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy

Country Status (3)

Country Link
AU (1) AU4543196A (en)
FR (1) FR2729399B1 (en)
WO (1) WO1996021733A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775694B1 (en) * 1998-03-06 2000-06-09 Gradient Ass TOXICITY TEST
EP1461087A1 (en) * 2001-12-06 2004-09-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69431295T2 (en) * 1993-04-21 2003-05-15 Pasteur Institut BIOCOMPATIBLE IMPLANT FOR IN VIVO EXPRESSION AND SECRETION OF THERAPEUTIC COMPOUND
CA2108606A1 (en) * 1993-10-15 1995-04-16 Jean-Louis Mandel X-linked adrenoleukodystrophy gene and corresponding protein

Also Published As

Publication number Publication date
WO1996021733A2 (en) 1996-07-18
FR2729399B1 (en) 1997-04-04
WO1996021733A3 (en) 1996-09-12
FR2729399A1 (en) 1996-07-19

Similar Documents

Publication Publication Date Title
AU3821689A (en) Enzyme electrodes and improvements in the manufacture thereof
AU6988596A (en) Photovoltaic cell
AU7612196A (en) Functional human hematopoietic cells
EP0870043B8 (en) Enhancer-increased gene expression in plants
AU6909198A (en) Leaf-specific gene expression in transgenetic plants
AU4702593A (en) Photovoltaic cell
AU2023995A (en) Electrochemical cell
GB9504446D0 (en) Improvements in or relating to gene expression
AU5154696A (en) Improvements in and relating to ovens
AU1989895A (en) Battery electrode interconnections
AU6855796A (en) In vivo electroporation of cells
AU4244793A (en) Human cell cycle checkpoint genes
AU3752293A (en) Photovoltaic cells
AU1471195A (en) Analog multiplier using multitail cell
AU6130196A (en) Cell treatment
AU5715394A (en) Solar cell arrangement
EP0662716A3 (en) Improvements in or relating to gate array cells.
AU4543196A (en) Transfert of dna in cells with the view to correcting the adrenoleucodystrophy
AU9276398A (en) Materials and methods relating to the stimulation of cells
AU5773698A (en) Improvements in or relating to electrodes
GB9605515D0 (en) Improvements in or relating to cell stimulation
AU4935896A (en) Gene expression in mammalian cells
AU7369394A (en) Photovoltaic cell and manufacturing process
GB9510709D0 (en) Solar combination cell
AU7064298A (en) Materials and methods relating to stabilising substances in cells